The decrease in expression of NGAL was observed in MDA-MB-231 cells treated with MGN and MGO complexes, which indicates that the tested complexes may reduce the ability to metastasize triple-negative breast cancer. This evidence concerns the gene LCN2 and triple-negative breast carcinoma.